東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

COPD = heterogeneity and personalize...

Lee, Sang-Do.

Linked to FindBook

Google Book

Amazon

博客來

COPD = heterogeneity and personalized treatment /

Record Type:	Electronic resources : Monograph/item
Title/Author:	COPD/ edited by Sang-Do Lee.
Reminder of title:	heterogeneity and personalized treatment /
other author:	Lee, Sang-Do.
Published:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2017.,
Description:	viii, 341 p. :ill., digital ;24 cm.
[NT 15003449]:	Overview -- Introduction: Summary -- Definition -- Epidemiology -- Risk Factors -- Pathology/Pathogenesis/Pathophysiology -- Assessment -- Introduction: Summary -- Symptoms: SGRQ, CAT, MRC -- Spirometry -- Images -- Biomarkers -- Comorbidity -- Heterogeneity -- Introduction: Summary -- Phenotypes of COPD -- Genetics -- Images -- ACOS -- Exacerbation -- Pulmonary Hypertension -- Management -- Introduction: Summary -- Prevention -- Pharmacologic -- Non-pharmacologic: LVR, Rehab, Nutritional support -- Management of exacerbation -- Management of Comorbidities -- Personalized Treatment: current practice and evidences from researches -- Prospective -- Cohort: KOLD, ANOLD; Big data, Network medicine.
Contained By:	Springer eBooks
Subject:	Lungs - Diseases, Obstructive. -
Online resource:	http://dx.doi.org/10.1007/978-3-662-47178-4
ISBN:	9783662471784

COPD = heterogeneity and personalized treatment /
COPDheterogeneity and personalized treatment /[electronic resource] :edited by Sang-Do Lee. - Berlin, Heidelberg :Springer Berlin Heidelberg :2017. - viii, 341 p. :ill., digital ;24 cm.

Overview -- Introduction: Summary -- Definition -- Epidemiology -- Risk Factors -- Pathology/Pathogenesis/Pathophysiology -- Assessment -- Introduction: Summary -- Symptoms: SGRQ, CAT, MRC -- Spirometry -- Images -- Biomarkers -- Comorbidity -- Heterogeneity -- Introduction: Summary -- Phenotypes of COPD -- Genetics -- Images -- ACOS -- Exacerbation -- Pulmonary Hypertension -- Management -- Introduction: Summary -- Prevention -- Pharmacologic -- Non-pharmacologic: LVR, Rehab, Nutritional support -- Management of exacerbation -- Management of Comorbidities -- Personalized Treatment: current practice and evidences from researches -- Prospective -- Cohort: KOLD, ANOLD; Big data, Network medicine.

This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.) Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous ill.. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset In clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.

ISBN: 9783662471784

Standard No.: 10.1007/978-3-662-47178-4doiSubjects--Topical Terms:

844163
Lungs
--Diseases, Obstructive.

LC Class. No.: RC776.O3

Dewey Class. No.: 616.24

COPD = heterogeneity and personalized treatment /
LDR:02740nmm a2200313 a 4500 001 2111108
003 DE-He213
005 20171010164004.0
006 m d
007 cr nn 008maaau
008 180619s2017 gw s 0 eng d
020 $a 9783662471784 $q (electronic bk.)
020 $a 9783662471777 $q (paper)
024 7 $a 10.1007/978-3-662-47178-4 $2 doi
035 $a 978-3-662-47178-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC776.O3
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
082 0 4 $a 616.24 $2 23
090 $a RC776.O3 $b C781 2017
245 0 0 $a COPD $h [electronic resource] : $b heterogeneity and personalized treatment / $c edited by Sang-Do Lee.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2017.
300 $a viii, 341 p. : $b ill., digital ; $c 24 cm.
505 0 $a Overview -- Introduction: Summary -- Definition -- Epidemiology -- Risk Factors -- Pathology/Pathogenesis/Pathophysiology -- Assessment -- Introduction: Summary -- Symptoms: SGRQ, CAT, MRC -- Spirometry -- Images -- Biomarkers -- Comorbidity -- Heterogeneity -- Introduction: Summary -- Phenotypes of COPD -- Genetics -- Images -- ACOS -- Exacerbation -- Pulmonary Hypertension -- Management -- Introduction: Summary -- Prevention -- Pharmacologic -- Non-pharmacologic: LVR, Rehab, Nutritional support -- Management of exacerbation -- Management of Comorbidities -- Personalized Treatment: current practice and evidences from researches -- Prospective -- Cohort: KOLD, ANOLD; Big data, Network medicine.
520 $a This book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.) Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous ill.. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset In clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide.
650 0 $a Lungs $x Diseases, Obstructive. $3 844163
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Pneumology/Respiratory System. $3 894348
650 2 4 $a Pathology. $3 643180
650 2 4 $a Diagnostic Radiology. $3 891111
700 1 $a Lee, Sang-Do. $3 3264865
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-47178-4
950 $a Medicine (Springer-11650)